• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三结构域蛋白 35 促进肺癌细胞在体外和体内的增殖、迁移和侵袭。

Tripartite motif containing 35 contributes to the proliferation, migration, and invasion of lung cancer cells in vitro and in vivo.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China.

School of Public Health, Nanchang University, Nanchang, Jiangxi 330006, China.

出版信息

Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200065.

DOI:10.1042/BSR20200065
PMID:32293015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7198043/
Abstract

The tripartite motif (TRIM) family is a family of proteins with highly conserved domains. Previous researches have suggested that the members of TRIM family proteins played a crucial role in cancer development and progression. Our study explored the relationship between TRIM35 and non-small cell lung cancer (NSCLC). The study showed that the expression of TRIM35 was increased in NSCLC samples, and patients with high expression of TRIM35 had a poor clinical prognosis. Overexpression of TRIM35 in NSCLC cell line H460 promoted cell proliferation, migration, and invasion, knockdown of TRIM35 produced an opposite result in A549 and H1299 cell lines. In vivo study further confirmed that overexpression of TRIM35 promoted tumor formation. The RNA-seq analysis suggested that TRIM35 might promote lung cancer proliferation, migration, and invasion by regulating cancer-associated functions and signaling pathways. Hence, we identified TRIM35 played a significant role in tumoral growth and was a potential diagnosis and prognosis target for lung cancer.

摘要

三结构域蛋白家族(TRIM)是一类具有高度保守结构域的蛋白家族。先前的研究表明,TRIM 家族蛋白成员在癌症的发生和发展中起着至关重要的作用。本研究探讨了 TRIM35 与非小细胞肺癌(NSCLC)之间的关系。研究表明,TRIM35 在 NSCLC 样本中的表达增加,并且高表达 TRIM35 的患者临床预后较差。在 NSCLC 细胞系 H460 中过表达 TRIM35 促进了细胞增殖、迁移和侵袭,而在 A549 和 H1299 细胞系中敲低 TRIM35 则产生了相反的结果。体内研究进一步证实,过表达 TRIM35 促进了肿瘤的形成。RNA-seq 分析表明,TRIM35 可能通过调节癌症相关功能和信号通路促进肺癌的增殖、迁移和侵袭。因此,我们确定 TRIM35 在肿瘤生长中起着重要作用,是肺癌潜在的诊断和预后靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/2a8190a7970e/bsr-40-bsr20200065-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/60e366fc034a/bsr-40-bsr20200065-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/db7fc16b31ef/bsr-40-bsr20200065-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/841f18e5672c/bsr-40-bsr20200065-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/2a8190a7970e/bsr-40-bsr20200065-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/60e366fc034a/bsr-40-bsr20200065-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/db7fc16b31ef/bsr-40-bsr20200065-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/841f18e5672c/bsr-40-bsr20200065-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ed5/7198043/2a8190a7970e/bsr-40-bsr20200065-g4.jpg

相似文献

1
Tripartite motif containing 35 contributes to the proliferation, migration, and invasion of lung cancer cells in vitro and in vivo.三结构域蛋白 35 促进肺癌细胞在体外和体内的增殖、迁移和侵袭。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200065.
2
SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.SNHG20 通过作为 miR-154 的海绵体抑制非小细胞肺癌的增殖、迁移和侵袭,并促进凋亡。
Biomed Pharmacother. 2019 Apr;112:108648. doi: 10.1016/j.biopha.2019.108648. Epub 2019 Feb 16.
3
miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.微小RNA-4417靶向含三联基序蛋白35(TRIM35)并调节丙酮酸激酶M2型(PKM2)磷酸化,以促进肝癌细胞增殖并抑制其凋亡。
Med Sci Monit. 2017 Apr 10;23:1741-1750. doi: 10.12659/msm.900296.
4
SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.SRPX2 通过激活非小细胞肺癌中的 FAK/SRC/ERK 通路促进细胞增殖和侵袭。
Acta Biochim Pol. 2020 Jun 18;67(2):165-172. doi: 10.18388/abp.2020_5158.
5
TRIM35 functions as a novel tumor suppressor in breast cancer by inducing cell apoptosis through ubiquitination of PDK1.TRIM35 通过泛素化 PDK1 诱导细胞凋亡,在乳腺癌中作为一种新型的肿瘤抑制因子发挥作用。
Neoplasma. 2022 Mar;69(2):370-382. doi: 10.4149/neo_2021_210823N1205. Epub 2022 Jan 28.
6
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
7
Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.敲低长链非编码 RNA DLX6-AS1 通过下调 PRR11 表达和上调 miR-144 抑制非小细胞肺癌细胞增殖、迁移和侵袭,促进细胞凋亡。
Biomed Pharmacother. 2019 Jan;109:1851-1859. doi: 10.1016/j.biopha.2018.09.151. Epub 2018 Nov 26.
8
MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.miR-126-3p 通过靶向 CCR1 抑制 NSCLC 的生长、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):679-689. doi: 10.26355/eurrev_201901_16881.
9
Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.PKMYT1的过表达预示着预后不良,并通过激活Notch信号通路增强非小细胞肺癌的增殖和肿瘤发生。
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4210-4219. doi: 10.26355/eurrev_201905_17925.
10
High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis.高 circ-SEC31A 表达通过调控 miR-520a-5p/GOT-2 轴预测非小细胞肺癌的不良预后。
Aging (Albany NY). 2020 Jun 4;12(11):10381-10397. doi: 10.18632/aging.103264.

引用本文的文献

1
Multifaceted role of in health and disease.[此处原文不完整,缺少具体所指内容]在健康与疾病中的多方面作用。
MedComm (2020). 2024 Nov 11;5(11):e790. doi: 10.1002/mco2.790. eCollection 2024 Nov.
2
Is MG53 a potential therapeutic target for cancer?MG53 是否是癌症的潜在治疗靶点?
Front Endocrinol (Lausanne). 2023 Nov 15;14:1295349. doi: 10.3389/fendo.2023.1295349. eCollection 2023.
3
TRIM family contribute to tumorigenesis, cancer development, and drug resistance.TRIM家族参与肿瘤发生、癌症发展和耐药过程。

本文引用的文献

1
RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.撤回:HBV 编码的 miR-2 通过下调 TRIM35 但上调 RAN 在肝癌细胞中发挥癌基因作用。
EBioMedicine. 2019 Oct;48:117-129. doi: 10.1016/j.ebiom.2019.09.012. Epub 2019 Sep 14.
2
TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.TRIM67 通过激活 p53 抑制结直肠肿瘤的发生和发展。
Cancer Res. 2019 Aug 15;79(16):4086-4098. doi: 10.1158/0008-5472.CAN-18-3614. Epub 2019 Jun 25.
3
EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer.
Exp Hematol Oncol. 2022 Oct 19;11(1):75. doi: 10.1186/s40164-022-00322-w.
4
TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect.TRIM35 泛素化调节 PKM2 四聚体和二聚体的表达,并通过调节瓦博格效应影响乳腺癌的恶性行为。
Int J Oncol. 2022 Dec;61(6). doi: 10.3892/ijo.2022.5434. Epub 2022 Oct 5.
5
A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.一种用于预测肾透明细胞癌预后的新型三联基序家族基因特征及其与免疫细胞浸润的关联
Front Oncol. 2022 Mar 17;12:840410. doi: 10.3389/fonc.2022.840410. eCollection 2022.
EMT:肺癌中逃避 EGFR 靶向治疗的机制。
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):29-39. doi: 10.1016/j.bbcan.2018.10.003. Epub 2018 Nov 10.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway.TRIM52 在与 NF-kB 通路相关的卵巢癌中发挥致癌作用。
Cell Death Dis. 2018 Sep 5;9(9):908. doi: 10.1038/s41419-018-0881-6.
6
Advances in antibody therapeutics targeting small-cell lung cancer.靶向小细胞肺癌的抗体疗法进展
Adv Clin Exp Med. 2018 Sep;27(9):1317-1323. doi: 10.17219/acem/70159.
7
EMT in cancer.肿瘤中的 EMT。
Nat Rev Cancer. 2018 Feb;18(2):128-134. doi: 10.1038/nrc.2017.118. Epub 2018 Jan 12.
8
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
9
Analytical performance of Envisia: a genomic classifier for usual interstitial pneumonia.Envisia:用于普通间质性肺炎的基因组分类器的分析性能。
BMC Pulm Med. 2017 Nov 17;17(1):141. doi: 10.1186/s12890-017-0485-4.
10
TRIM proteins in blood cancers.血液癌症中的TRIM蛋白
J Cell Commun Signal. 2018 Mar;12(1):21-29. doi: 10.1007/s12079-017-0423-5. Epub 2017 Nov 6.